Genetic Polymorphism of Angiotensin Converting Enzyme and Risk of Coronary Restenosis after Percutaneous Transluminal Coronary Angioplasties: Evidence from 33 Cohort Studies
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.